General
Oxford-AstraZeneca vaccine shows promise in elderly, trial results by Christmas
Oxford University and AstraZeneca’s potential COVID-19 vaccine produced a strong immune response in older adults, newly published data has showed, with researchers expecting to release late-stage trial results by Christmas.
Key points:
- Late stage Oxford-AstraZeneca trials have shown it develops antibody and T-cell responses in elderly patients
- Rival drugmakers Pfizer-BioNTech and Moderna have recently pushed ahead in the race for a COVID vaccine
- Researchers report no serious side effects from the Oxford-AstraZeneca vaccine
The data, reported in part last month but published in full in The Lancet medical journal on Thursday, suggest that those aged over 70, who are at higher risk of serious illness and death from COVID-19, could build robust…
-
General13 hours agoBoy dies in foyer of Queensland police station after crash at Ormeau
-
Noosa News19 hours agoMS is not holding Lynda MacCallum back from staying in the saddle
-
Business18 hours agoUp 117% in six months! Pilbara Minerals shares lead the charge as ASX lithium stocks rally
-
Noosa News16 hours agoFamily rush to Beenleigh Police Station in Queensland with critically injured child following crash